BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26836268)

  • 1. Docosahexaenoic Acid-Rich Fish Oil Supplementation Improves Body Composition without Influence of the PPARγ Pro12Ala Polymorphism in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Mansoori A; Sotoudeh G; Djalali M; Eshraghian MR; Keramatipour M; Nasli-Esfahani E; Shidfar F; Alvandi E; Toupchian O; Koohdani F
    J Nutrigenet Nutrigenomics; 2015; 8(4-6):195-204. PubMed ID: 26836268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of DHA-rich fish oil on PPARγ target genes related to lipid metabolism in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial.
    Mansoori A; Sotoudeh G; Djalali M; Eshraghian MR; Keramatipour M; Nasli-Esfahani E; Shidfar F; Alvandi E; Toupchian O; Koohdani F
    J Clin Lipidol; 2015; 9(6):770-777. PubMed ID: 26687697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DHA-enriched fish oil upregulates cyclin-dependent kinase inhibitor 2A (P16
    Toupchian O; Sotoudeh G; Mansoori A; Abdollahi S; Ali Keshavarz S; Djalali M; Nasli-Esfahani E; Alvandi E; Chahardoli R; Koohdani F
    Clin Nutr; 2018 Feb; 37(1):91-98. PubMed ID: 28024882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DHA supplementation during pregnancy does not reduce BMI or body fat mass in children: follow-up of the DHA to Optimize Mother Infant Outcome randomized controlled trial.
    Muhlhausler BS; Yelland LN; McDermott R; Tapsell L; McPhee A; Gibson RA; Makrides M
    Am J Clin Nutr; 2016 Jun; 103(6):1489-96. PubMed ID: 27030533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.
    Franks PW; Jablonski KA; Delahanty L; Hanson RL; Kahn SE; Altshuler D; Knowler WC; Florez JC;
    Diabetologia; 2007 Dec; 50(12):2451-60. PubMed ID: 17898990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of docosahexaenoic acid-enriched fish oil supplementation in pregnant women with Type 2 diabetes on membrane fatty acids and fetal body composition--double-blinded randomized placebo-controlled trial.
    Min Y; Djahanbakhch O; Hutchinson J; Bhullar AS; Raveendran M; Hallot A; Eram S; Namugere I; Nateghian S; Ghebremeskel K
    Diabet Med; 2014 Nov; 31(11):1331-40. PubMed ID: 24925713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-chain polyunsaturated fatty acid supplementation had no effect on body weight but reduced energy intake in overweight and obese women.
    Harden CJ; Dible VA; Russell JM; Garaiova I; Plummer SF; Barker ME; Corfe BM
    Nutr Res; 2014 Jan; 34(1):17-24. PubMed ID: 24418242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
    Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
    Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of DHA-enriched fish oil on gene expression levels of p53 and NF-κB and PPAR-γ activity in PBMCs of patients with T2DM: A randomized, double-blind, clinical trial.
    Naeini Z; Toupchian O; Vatannejad A; Sotoudeh G; Teimouri M; Ghorbani M; Nasli-Esfahani E; Koohdani F
    Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):441-447. PubMed ID: 31831363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of DHA-enriched fish oil on monocyte/macrophage activation marker sCD163, asymmetric dimethyl arginine, and insulin resistance in type 2 diabetic patients.
    Toupchian O; Sotoudeh G; Mansoori A; Nasli-Esfahani E; Djalali M; Keshavarz SA; Koohdani F
    J Clin Lipidol; 2016; 10(4):798-807. PubMed ID: 27578110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of DHA Supplementation on Vascular Function, Telomerase Activity in PBMC, Expression of Inflammatory Cytokines, and PPARγ-LXRα-ABCA1 Pathway in Patients With Type 2 Diabetes Mellitus: Study Protocol for Randomized Controlled Clinical Trial.
    Toupchian O; Sotoudeh G; Mansoori A; Djalali M; Keshavarz SA; Nasli-Esfahani E; Alvandi E; Koohdani F
    Acta Med Iran; 2016 Jul; 54(7):410-7. PubMed ID: 27424010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARγ Pro12Ala Polymorphism Influences the Relationship between Dietary Fat Intake, Adiposity and Lipid Profile in Patients with Type 2 Diabetes.
    Koohdani F; Sotoudeh G; Kalantar Z; Mansoori A
    Int J Vitam Nutr Res; 2018 Dec; 88(5-6):263-269. PubMed ID: 31188078
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of polymorphism pro12Ala of PPARgamma gene on endothelium destruction in patients with diabetes mellitus t. 2].
    Gacka M; Dobosz T; Szymaniec S; Bednarska-Chabowska D; Adamiec R
    Pol Arch Med Wewn; 2005 Nov; 114(5):1055-65. PubMed ID: 16789503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Double-Blinded, Placebo-Controlled Trial Investigating the Effect of Fish Oil Supplementation on Gene Expression Related to Insulin Action, Blood Lipids, and Inflammation in Gestational Diabetes Mellitus-Fish Oil Supplementation and Gestational Diabetes.
    Jamilian M; Samimi M; Mirhosseini N; Afshar Ebrahimi F; Aghadavod E; Taghizadeh M; Asemi Z
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
    Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
    Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTO T/A and peroxisome proliferator-activated receptor-γ Pro12Ala polymorphisms but not ApoA1 -75 are associated with better response to lifestyle intervention in Brazilians at high cardiometabolic risk.
    Curti ML; Rogero MM; Baltar VT; Barros CR; Siqueira-Catania A; Ferreira SR
    Metab Syndr Relat Disord; 2013 Jun; 11(3):169-76. PubMed ID: 23438152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fish oil supplementation on quality of life in a general population of older Dutch subjects: a randomized, double-blind, placebo-controlled trial.
    van de Rest O; Geleijnse JM; Kok FJ; van Staveren WA; Olderikkert MG; Beekman AT; de Groot LC
    J Am Geriatr Soc; 2009 Aug; 57(8):1481-6. PubMed ID: 19549020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid-rich fish oil improves heart rate variability and heart rate responses to exercise in overweight adults.
    Ninio DM; Hill AM; Howe PR; Buckley JD; Saint DA
    Br J Nutr; 2008 Nov; 100(5):1097-103. PubMed ID: 18339222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PPARgamma Pro12Ala polymorphism is not associated with body mass index or waist circumference among Hispanics from Colorado.
    Nelson TL; Fingerlin TE; Moss L; Barmada MM; Ferrell RE; Norris JM
    Ann Nutr Metab; 2007; 51(3):252-7. PubMed ID: 17587797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating CD36+ microparticles are not altered by docosahexaenoic or eicosapentaenoic acid supplementation.
    Phang M; Thorne RF; Alkhatatbeh MJ; Garg ML; Lincz LF
    Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):254-60. PubMed ID: 26803595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.